Home | Business News | Browse by Publication | F | FDA Consumer

First treatment for hunter syndrome.

Publication: FDA Consumer
Publication Date: 01-NOV-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: First treatment for hunter syndrome.(Elaprase from Shire Human Genetic Therapies Inc.)(Brief article)

Article Excerpt
Elaprase, the first product for the treatment of Hunter syndrome (Mucopolysaccharidosis II, or MPS II), has been approved by the FDA. Elaprase, approved in July 2006, is a new molecular entity--an active ingredient never before marketed in the United States.

Hunter syndrome is a rare inherited disease that can...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
Warning against drinking hydrogen peroxide.(Brief article), November 01, 2006
Generic drugs for osteoarthritis.(Mobic from Boehringer Ingelheim GmbH..., November 01, 2006
The FDA: fresh leafy greens grown in the United States are safe., November 01, 2006
The FDA broadens access to lead screening test.(Food and Drug Administ..., November 01, 2006
The importance of patient-reported outcomes ... it's all about the pat..., November 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.